These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
GLP-1 and GIP both participate in incretin biology, while glucagon receptor activation may influence energy expenditure, fat oxidation, and liver metabolism
The single-dose pen simplifies the injection process, eliminating the need to handle a needle directly
Many patients diagnosed with IBS actually have SIBO as the underlying driver
They have an injury secondary to inflammation or something like that
B12 injections are generally considered safe, especially since vitamin B12 is water-soluble, meaning the body naturally expels excess amounts